Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | PRT318 |
Synonyms | |
Therapy Description |
PRT318 is a selective inhibitor of SYK, which leads to decreased B-cell receptor signaling and decreased tumor cell viability (PMID: 22362000). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PRT318 | PRT-060318 | SYK Inhibitor 15 | PRT318 is a selective inhibitor of SYK, which leads to decreased B-cell receptor signaling and decreased tumor cell viability (PMID: 22362000). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|